Bibliografia

1. Ribard P, Audiso F, Kahn MF, et al. Seven Achilles tendonitis cases including 3 complicated by rupture during fluoroquinolone therapy. J Rheumatol 1992; 19(9): 1479-81.
2. Kato M, Takada S, Kashida Y, Nomura M. Histological examination on Achilles tendon lesions induced by quinolone antibacterial agents in juvenile rats. Toxicol Pathol 1995; 23(3): 385-92.
3. Dirks RC, Warden SJ. Models for the study of tendinopathy. J Musculoskeletal Neuronal Iteract. 2011; 11(2): 141-9.
4. Vanek D, Saxena A, Boggs JM. Fluoroquinolone therapy and Achilles tendon rupture. J Am Podiatr Med Assoc 2003; 93: 333-5.
5. van der Linden P, Sturkenboom M, Herings R, et al. Increased risk of Achilles tendon rupture with quinolone antibacterial use, especially in elderly patients taking oral corticosteroids. Arch Intern Med 2003; 163: 1801-7.
6. Filippucci E, Farina A, Bartolucci F, et al. Fluoroquinolone-induced bilateral rupture of the Achilles tendon: clinical and sonographic findings. Reumatismo, 2003; 55(4):267-269.
7. Royer RJ, Pierfitte C, Netter P. Features of tendon disorders with fluoroquinolones. Therapie 1994; 49:75-6.
8. Corps AN, Harral RL, Curry VA, et al. Ciprofloxacin enhances the simulation of matrix metalloproteinase 3 expression by interlukin 1beta in human tendon derived cells. A potential mechanism of fluoroquinolone-induced tendinopathy. Arthritis Rheum 2002; 46: 3034-40.
9. Bernard-Beaubois K, Hecquet C, Hayem G, Rat P, Adolphe M. In vitro study of cytotoxicity of quinolones on rabbit tenocytes. Cell Biol Toxicol 1998; 14: 283-92.